Intestinal Microbiota in Pediatric Surgical Cases Administered Bifidobacterium Breve: A Randomized Controlled Trial
- 2016-07
- Journal of Pediatric Gastroenterology and Nutrition 63(1)
- T. Okazaki
- T. Asahara
- A. Yamataka
- Yuki Ogasawara
- Geoffrey J. Lane
- K. Nomoto
- S. Nagata
- Y. Yamashiro
- PubMed: 26859092
- DOI: 10.1097/MPG.0000000000001140
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Population
- Pediatric surgical patients
- Methods
- Controlled experimental study
Abstract
The efficacy of perioperative probiotic administration has been reported in adults. We examined the effects of orally administered Bifidobacterium breve strain Yakult (BBG-01) on outcomes in pediatric surgical cases by assessing intestinal and blood microbiota. BBG-01 was well tolerated without adverse effects, and postoperative infectious complications were significantly decreased. Fecal analysis showed increased Bifidobacterium and decreased Enterobacteriaceae, Clostridium difficile, and Pseudomonas. Concentrations of fecal acetic acid were significantly increased, maintaining fecal pH at <7.0. The incidence of detecting bacteria in blood was significantly reduced. BBG-01 improved the intestinal environment, and may be implicated in suppressing bacterial translocation.
Research Insights
Fecal analysis showed increased Bifidobacterium.
- Effect
- Beneficial
- Effect size
- Moderate
Concentrations of fecal acetic acid were significantly increased
- Effect
- Beneficial
- Effect size
- Moderate
The incidence of detecting bacteria in blood was significantly reduced.
- Effect
- Beneficial
- Effect size
- Moderate
Fecal analysis showed... decreased Clostridium difficile
- Effect
- Beneficial
- Effect size
- Moderate
Fecal analysis showed... decreased Enterobacteriaceae
- Effect
- Beneficial
- Effect size
- Moderate
postoperative infectious complications were significantly decreased.
- Effect
- Beneficial
- Effect size
- Large
Fecal analysis showed... decreased Pseudomonas
- Effect
- Beneficial
- Effect size
- Moderate